Genistein
- Generic Name
- Genistein
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H10O5
- CAS Number
- 446-72-0
- Unique Ingredient Identifier
- DH2M523P0H
- Background
An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.
...
- Indication
Currently Genistein is being studied in clinical trials as a treatment for prostate cancer.
- Associated Conditions
- Calcium Deficiency, Deficiency, Vitamin D, Osteodystrophy, Osteomalacia, Osteoporosis
- Associated Therapies
- -
Complex IIa formation and ABC transporters determine sensitivity of OSCC to Smac mimetics
Head and neck squamous cell carcinoma: risk factors, molecular alterations, immunology, and peptide vaccines.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath